Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

AstraZeneca PLC ADR (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AstraZeneca ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
53.06 -1.52    -2.78%
20:02:54 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 7,352,508
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 52.65 - 54.01
Type:  Equity
Market:  United States
AstraZeneca ADR 53.06 -1.52 -2.78%

AZN Income Statement

 
Assess the Astrazeneca income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2022
31/03
2021
31/12
2021
30/09
2021
30/06
Total Revenue 11390 12011 9866 8220
Revenue 11390 12011 9866 8220
Other Revenue, Total - - - -
Cost of Revenue, Total 2279 3069 3824 2193
Gross Profit 9111 8942 6042 6027
Total Operating Expenses 10512 12303 11540 7093
Selling/General/Admin. Expenses, Total 3057 4082 2986 2574
Research & Development 2186 2927 2153 1801
Depreciation / Amortization 1098 1066 1209 385
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) 2025 1007 1405 269
Other Operating Expenses, Total -133 152 -37 -129
Operating Income 878 -292 -1674 1127
Interest Income (Expense), Net Non-Operating -325 -344 -327 -363
Gain (Loss) on Sale of Assets - - - -
Other, Net - - - -
Net Income Before Taxes 553 -636 -2001 764
Provision for Income Taxes 165 -290 -350 214
Net Income After Taxes 388 -346 -1651 550
Minority Interest -2 -1 -1 -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 386 -347 -1652 550
Total Extraordinary Items - - - -
Net Income 386 -347 -1652 550
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 386 -347 -1652 550
Dilution Adjustment - - - -
Diluted Net Income 386 -347 -1652 550
Diluted Weighted Average Shares 1561 1550 1496 1318
Diluted EPS Excluding Extraordinary Items 0.25 -0.22 -1.1 0.42
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 1.34 1.01 0.14 0.57
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai May 09, 2021 11:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks you AstraZ. Bullish. management services.
Woon soo Lee
Woon soo Lee May 01, 2021 18:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
54 to 64 bullish sentiments again volatility trading
Poh Meng Kong
Poh Meng Kong Feb 25, 2021 22:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$68 in 1 month
Nelson T Machin
Nelson T Machin Feb 01, 2021 15:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you this will grow as EU has approved their Covid vaccine?
Frans Caruana
Frans Caruana Jan 25, 2021 20:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will reach 100 in 6 months time
Arek Rusak
Arek Rusak Dec 24, 2020 13:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think the vaccine is nothing next to the antibody coctail, known as AZD7442 that Astra is working on at the momenthttps://www.reuters.com/article/health-coronavirus-astrazeneca-antibody-idUSKBN28100E
bojidar zarev
bojidar zarev Dec 14, 2020 18:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good buy in the long term.
Andre Low
Andre Low Dec 12, 2020 13:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.wsj.com/articles/astrazeneca-agrees-to-buy-alexion-for-39-billion-11607778687?redirect=amp#click=https://t.co/EeYlRyEn3g
Nabeel Qabane
Nabeel Qabane Nov 30, 2020 10:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I expect it to reach $ 100 next month
Sandeep Agarwal
Sandeep Agarwal Oct 12, 2020 17:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
for super rich returns
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email